ZOLL wins rights to Vyaire’s vent biz
By HME News Staff
Updated 10:53 AM CDT, Tue September 3, 2024
CHELMSFORD, Mass. – ZOLL has announced it is the winning bidder in an auction to buy Vyaire Medical’s ventilator business as part of the company’s Chapter 11 bankruptcy proceedings. Completion of the acquisition is subject to court approval at a sale hearing and dependent on a successful closing that is anticipated to occur in the coming weeks. “Respiratory care has been central to ZOLL’s business strategy for many years,” said Jon Rennert, CEO of ZOLL. “If the acquisition is successfully completed, adding Vyaire’s ventilators to ZOLL’s product portfolio will enhance our ability to serve a broader range of clinicians and patients.” Vyaire Medical announced in June it had voluntarily filed for Chapter 11 bankruptcy protection in the U.S. The Chapter 11 filing allowed Vyaire to continue to operate while seeking to sell its business units, including the Vyaire ventilation business. ZOLL, an Asahi Kasei company, provides a comprehensive set of technologies, including defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment that help clinicians, EMS and fire professionals, as well as lay rescuers.
Comments